Table 1.
Baseline patient characteristics.
| BASELINE CHARACTERISTICS | FRESH-ET (n = 339) | DEFERRED-ET (n = 389) | p-VALUE |
|---|---|---|---|
| AGE (YEARS) * | 35.5 ± 0.2 | 35.9 ± 0.3 | 0.34 |
| BMI (KG/M2) * | 22.2 ± 0.1 | 22.4 ± 0.2 | 0.51 |
| DURATION OF INFERTILITY (YEARS) * | 2.8 ± 0.3 | 2.9 ± 0.3 | 0.31 |
| OVARIAN RESERVE | |||
| AMH (NG/ML) * | 3.4 ± 1.8 | 4.3 ± 2.2 | 0.18 |
| AFC * | 7.6 ± 2.7 | 8.9 ± 1.1 | 0.16 |
| GRAVIDITY | 0.12 | ||
| 0 | 91.6% | 91.2% | |
| ≥1 | 8.4% | 8.8% | |
| PARITY | 0.25 | ||
| 0 | 94.8% | 94.3% | |
| ≥1 | 5.2% | 5.7% | |
| ASSOCIATED MALE INFERTILITY | 3.2% | 2.9% | 0.37 |
| ENDOMETRIOSIS I-II STAGE | 37.6% | 39.7% | 0.24 |
| ENDOMETRIOSIS III-IV STAGE | 62.4% | 60.3% | 0.17 |
| TOTAL DOSES OF FSH (IU) * | 1686 ± 46 | 1673 ± 64 | 0.14 |
| TOTAL DOSES OF HMG (IU) * | 1004 ± 95 | 962 ± 121 | 0.47 |
* values presented as mean ± SD. n = number of study participants.